|
KIF18A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.758020E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.816000E-02 |
| Normal-vs-Stage2 |
3.763700E-04 |
| Normal-vs-Stage3 |
2.943100E-03 |
| Normal-vs-Stage4 |
1.945800E-02 |
| Stage1-vs-Stage2 |
1.221470E-04 |
| Stage1-vs-Stage3 |
3.237000E-03 |
| Stage1-vs-Stage4 |
2.502200E-01 |
| Stage2-vs-Stage3 |
1.186780E-01 |
| Stage2-vs-Stage4 |
2.555600E-02 |
| Stage3-vs-Stage4 |
2.659400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.368000E-02 |
| Normal-vs-AfricanAmerican |
3.334400E-01 |
| Normal-vs-Asian |
2.086600E-01 |
| Caucasian-vs-AfricanAmerican |
5.727600E-01 |
| Caucasian-vs-Asian |
4.807800E-01 |
| AfricanAmerican-vs-Asian |
9.647000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.644700E-03 |
| Normal-vs-Female |
2.438200E-02 |
| Male-vs-Female |
2.866000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.313980E-01 |
| Normal-vs-Age(41-60Yrs) |
8.058400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.520200E-03 |
| Normal-vs-Age(81-100Yrs) |
8.229600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.099510E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.801500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.671400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.508000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.696800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.532200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.925400E-01 |
| Classical-VS-Follicular |
6.0551563763056E-13 |
| Classical-VS-Other |
8.222400E-01 |
| Classical-VS-Normal |
9.774200E-02 |
| Tall-VS-Follicular |
2.28820000000018E-05 |
| Tall-VS-Other |
6.977600E-01 |
| Tall-VS-Normal |
6.180000E-02 |
| Follicular-VS-Other |
9.370200E-02 |
| Follicular-VS-Normal |
2.38649999999563E-05 |
| Other-VS-Normal |
6.048400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.377000E-03 |
| Normal-vs-N1 |
1.649770E-02 |
| N0-vs-N1 |
3.146200E-01 |
|
|
